Topic

All

12
Oct
2021

5 Themes to Track at ASHG 2021

Please subscribe and tell your friends why it’s worthwhile. Quality journalism costs money. When you subscribe to Timmerman Report at $169 per year, you reward quality independent biotech reporting, and encourage more.   Subscribe Now   Sign in to your account.
4
Oct
2021

Pharma’s Digital Transformation: Enduring Challenges, Sustained Hopes, And A Progress Report From Lilly’s CEO

When it comes to emerging digital and data technologies, most pharma CEOs today are singing from the same hymnal. They all emphasize their commitment to digital transformation, and assert that the adoption of digital processes are key to their companies’ success, and vital for the industry’s future.  A recent Lazard survey of healthcare leaders echoes this message. The investment bank...
Read More
20
Sep
2021

A Magical Time in the Presidential Range, Giving Back to Community

The Timmerman Traverse for Life Science Cares was everything I dreamed it would be. Here’s a quick recap: The team of 20 raised $706,000 to fight poverty 51 sponsors participated About 530 individuals contributed We lucked out with the weather For those unfamiliar, the Timmerman Traverse for Life Science Cares brought together a team of 20 biotech executives and investors...
Read More
20
Sep
2021

What Should I Read? A Few Suggestions for Biotech Pros

Although we are all impossibly busy, most people I know in the biotech industry still make time to read books.  Books may sometimes have a hard time competing with flashier forms of media in the online attention economy, but they aren’t going away anytime soon. This seems especially true now that so many titles are available in audiobook form, enabling...
Read More
15
Sep
2021

Hero Narratives Inspire Entrepreneurs But Obscure Uncomfortable Trade-Offs

In today’s Wall Street Journal, I discuss Reid Hoffman’s Masters of Scale, a new book by the renowned Silicon Valley entrepreneur (PayPal, LinkedIn), investor (Facebook, Airbnb), and podcast host that proposes to distill the secrets of successful business and social entrepreneurs.  The review speaks for itself, of course, but Hoffman’s account, and others like it (there are many – for...
Read More
12
Sep
2021

Turning Around COVID Diagnostics. Mara Aspinall on The Long Run

Today’s guest on The Long Run is Mara Aspinall. Mara is a veteran diagnostics executive, investor, and educator. She’s a venture investor with Bluestone Venture Partners, the CEO of Health Catalysts (a consulting firm), and the co-founder and professor of the practice of biomedical diagnostics at Arizona State University. It’s the only program of its kind in the country, designed...
Read More
1 2 3 53